Form 4: Director John Chidsey Increases HCA Healthcare Stake

Director John Chidsey acquired 809 shares of HCA Healthcare common stock via restricted share units as part of his annual director compensation.

Summary

• Director John Chidsey received 809 restricted share units (RSUs) on April 28, 2026.
• The award consists of 509 RSUs for annual director equity and 300 RSUs in lieu of an annual cash retainer.
• The RSUs are scheduled to vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.
• Following this transaction, the director holds 1,305 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Director demonstrates alignment with shareholder interests by accepting equity in lieu of cash compensation.
• The acquisition increases the director's direct ownership stake in the company.

Negatives

• None identified.

Risks

• Vesting of the units is subject to continued service as a director until the 2027 annual meeting or the first anniversary of the grant.

Future Outlook

The restricted share units will vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Industry Context

StockSavvy.ai notes that director equity compensation in lieu of cash is a standard governance practice in the healthcare sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The practice of granting RSUs to directors is consistent with compensation structures at major healthcare peers like Tenet Healthcare and Universal Health Services.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased director equity alignment.

Next Steps

• Vesting of the 809 restricted share units in 2027.

Key Dates

Keywords

HCA Healthcare, Insider Trading, Form 4, Director Compensation, Equity Award